Sanofi India Ltd — Board/Management Information 2025

Apr 9, 2025

==> picture [113 x 30] intentionally omitted <==

9[th] April 2025

The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, 5[th] Floor, Dalal Street Plot No. C/1, G Block Mumbai 400 001 Bandra-Kurla Complex, Bandra East, Scrip Code: 500674 Mumbai 400 050 Symbol: SANOFI

Sub: Outcome of the Board Meeting of the Company held on Wednesday, 9[th] April 2025

Dear Sirs/Madam,

Pursuant to the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Rodolfo Hrosz, Managing Director of the Company, has intimated the Board of Directors today about his decision to step down from his current role, in view of his movement to another role within the Sanofi group. The Board of Directors have accepted his resignation and place on record their immense appreciation for Mr. Rodolfo Hrosz’s valuable contribution during his tenure as the Managing Director with the Company. Accordingly, he shall cease to be the Managing Director of the Company and shall also cease to be a Key Managerial Personnel, Senior Management Personnel and member of the Board Committees effective from the close of business hours on 30[th] April 2025.

The Board will take necessary steps to appoint a suitable successor as the Managing Director of the Company in due course.

Further, upon recommendation of the Nomination and Remuneration Committee and subject to the approval of the Shareholders, the Board of Directors have approved the appointment of Mr. Rodolfo Hrosz as an Additional Non-Executive Director of the Company with effect from 1[st] May 2025.

The information required in terms of Regulation 30 read with Schedule Ill - Para A (7) and (7C) of Part A of the Listing Regulations and SEBI Circular bearing Ref. No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13[th] July 2023 is enclosed as ‘Annexure-I’ to this letter

The meeting of Board of Directors commenced at 3:45 p.m. and concluded at 4.40 p.m.

Please take the above information on record.

Thanking you,

Yours faithfully For Sanofi India Limited

Digitally signed by Arjun Jasvant Arjun Jasvant Thakkar Thakkar Date: 2025.04.09 16:45:13 +05'30'

__________________

Arjun Thakkar Company Secretary and Compliance Officer Membership No.: A22654

Encl:

1) Annexure - I

2) Resignation Letter

Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: igrc.sil@sanofi.com

Annexure – I

==> picture [113 x 30] intentionally omitted <==

Information as required under Regulation 30 read with Schedule Ill - Para A of Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Sr.No.	Particulars	Details
		Mr. Rodolfo Hrosz, Managing Director of the
		Company will step down from his current role, in view
		of his movement to another role within the Sanofi
		group. As a result of such movement, he shall cease
1.	Reason for change viz.appointment, re-appointment,resignation, removal, death orotherwise;	to be the Managing Director of the Company andshall also cease to be a Key Managerial Personnel,Senior Management Personnel and member of theBoard Committees effective from the close ofbusiness hours on 30thApril 2025. Further, Mr.
		Rodolfo Hrosz will continue to be engaged with the
		Company as a Non-Executive Director with effect
		from 1stMay 2025, subject to the approval of the
		Members at the ensuingAGM.
	Date of appointment / re-	Cessation as the Managing Director of the Company
2.	appointment / cessation (asapplicable) & term of	with effect from the close of business hours on 30thApril 2025 and change in designation as Non-
	appointment;	Executive Director with effect from 1stMay 2025.
3.	Brief profile (in case ofappointment)	Not Applicable
		Mr. Rodolfo Hrosz is not related to any of the
4.	Disclosure of relationshipsbetween directors (in case ofappointment of a director).	Directors of the Company personally, financially orotherwise and is not debarred or disqualified frombeing appointed or continuing as director ofcompanies by SEBI / Ministry of Corporate Affairs or
		any such statutory authority

Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: igrc.sil@sanofi.com